Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: The VALIANT experience

Heart Rhythm

Volumn 4, Issue 3, 2007, Pages 308-313

  Stephenson, Kent ^a   Skali, Hicham ^a   McMurray, John J V ^b   Velazquez, Eric J ^c   Aylward, Philip G ^d   Kober, Lars ^e   Van de Werf, Frans ^f   White, Harvey D ^g   Pieper, Karen S ^c   Califf, Robert M ^c   Solomon, Scott D ^a   Pfeffer, Marc A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b WESTERN INFIRMARY   (United Kingdom)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d FLINDERS MEDICAL CENTRE   (Australia)

^e Rigshospitalet   (Denmark)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Heart failure; Left bundle branch block; Left ventricular systolic dysfunction; Mortality; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; FIBRINOLYTIC AGENT; POTASSIUM SPARING DIURETIC AGENT; VALSARTAN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; DEATH; ELECTROCARDIOGRAPHY; EXPERIENCE; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HIGH RISK PATIENT; HUMAN; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SURVIVOR;

AGED; AGED, 80 AND OVER; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BUNDLE-BRANCH BLOCK; CAPTOPRIL; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RESEARCH DESIGN; RISK FACTORS; STROKE VOLUME; SURVIVAL ANALYSIS; SURVIVORS; TETRAZOLES; TIME FACTORS; TREATMENT OUTCOME; VALINE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33847314814     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2006.11.021     Document Type: Article

References (27)

1. Pfeffer M.A., Braunwald E., Moye L.A., Basta L., Brown Jr. E.J., Cuddy T.E., Davis B.R., Geltman E.M., Goldman S., Flaker G.C., et al., The SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 327 (1992) 669-677
2. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342 (1993) 821-828
3. Kober L., Torp-Pedersen C., Carlson J.E., Bagger H., Eliasen P., Lyngborg K., Videbaek J., Cole D.S., Auclert L., Pauly N.C., and Trandolapril Cardiac Evaluation (TRACE) Study Group. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 333 (1995) 1670-1676
4. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardio. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 343 (1994) 1115-1122
5. Solomon S.D., Zelenkofske S., McMurray J.J., Finn P.V., Velazquez E., Ertl G., Harsanyi A., Rouleau J.L., Maggioni A., Kober L., White H., Van de Werf F., Pieper K., Califf R.M., Pfeffer M.A., and Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 352 (2005) 2581-2588
6. Go A.S., Barron H.V., Rundle A.C., Ornato J.P., Avins A.L., and National Registry of Myocardial Infarction 2 Investigators. Bundle-branch block and in-hospital mortality in acute myocardial infarction. Ann Intern Med 129 (1998) 690-697
7. Wong C.K., Stewart R.A., Gao W., French J.K., Raffel C., and White H.D. Prognostic differences between different types of bundle branch block during early phase of acute myocardial infarction: insights from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 Trial. Eur Heart J 27 (2006) 21-28
8. Bauer A., Watanabe M.A., Barthel P., Schneider R., Ulm K., and Schmidt G. QRS duration and late mortality in unselected post-infarction patients of the revascularization area. Eur Heart J 27 (2006) 427-433
9. Cannon C.P., McCabe C.H., Stone P.H., Rogers W.J., Schactman M., Thompson B.W., Pearce D.J., Diver D.J., Kells C., Feldman T., Williams M., Gibson R.S., Kronenberg M.W., Ganz L.I., Anderson H.V., and Braunwald E. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia. J Am Coll Cardiol 30 (1997) 133-140
10. Stenestrand U., Tabrizi F., Lindback J., Englund A., Rosenqvist M., and Wallentin L. Comorbidity and myocardial dysfunction are the main explanations for the higher 1-year mortality in acute myocardial infarction with left bundle-branch block. Circulation 110 (2004) 1896-1902
11. Pfeffer M.A., McMurray J.J., Velazquez E.J., Rouleau J.L., Kober L., Maggioni A.P., Solomon S.D., Swedberg K., Van de Werf F., White H., Leimberger J.D., Henis M., Edwards S., Zelenkofske S., Sellers M.A., and Califf R.M. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349 (2003) 1893-1906
12. Pfeffer M.A., McMurray J., Leizorovicz A., Maggioni A.P., Rouleau J.L., Van de Werf F., Henis M., Neuhart E., Gallo P., Edwards S., Sellers M.A., Velazquez E., and Califf R. Valsartan in acute myocardial infarction trial (VALIANT): rationale and design. Am Heart J 140 (2000) 727-750
13. Norris R.M., and Croxson M.S. Bundle branch block in acute myocardial infarction. Am Heart J 79 (1970) 728-733
14. Hindman M.C., Wagner G.S., JaRo M., Atkins J.M., Scheinman M.M., DeSanctis R.W., Hutter Jr. A.H., Yeatman L., Rubenfire M., Pujura C., Rubin M., and Morris J.J. The clinical significance of bundle branch block complicating acute myocardial infarction. 1. Clinical characteristics, hospital mortality, and one-year follow-up. Circulation 58 (1978) 679-688
15. Gould L., Ramana C.V., and Gomprecht R.F. Left bundle-branch block. Prognosis in acute myocardial infarction. JAMA 225 (1973) 625-627
16. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results of all randomised trials of more than 1000 patients. Lancet 343 (1994) 311-322
17. Sgarbossa E.B., Pinski S.L., Barbagelata A., Underwood D.A., Gates K.B., Topol E.J., Califf R.M., Wagner G.S., and GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators. Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. N Engl J Med 334 (1996) 481-487
18. Shlipak M.G., Go A.S., Frederick P.D., Malmgren J., Barron H.V., Canto J.G., and National Registry of Myocardial Infarction 2 Investigators. Treatment and outcomes of left bundle-branch block patients with myocardial infarction who present without chest pain. J Am Coll Cardiol 36 (2000) 706-712
19. Wong C.K., French J.K., Aylward P.E., Stewart R.A., Gao W., Armstrong P.W., Van de Werf F.J., Simes R.J., Raffel O.C., Granger C.B., Califf R.M., White H.D., and HERO-2 Trial Investigators. Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes. J Am Coll Cardiol 46 (2005) 29-38
20. Miller W.L., Squra F.A., Kopecky S.L., Asirvatham S.J., Williams B.A., Wright R.S., and Reeder G.S. Characteristics of presenting electrocardiograms of acute myocardial infarction from a community-based population predict short- and long-term mortality. Am J Cardiol 87 (2001) 1045-1050
21. Go A.S., Barron H.V., Rundle A.C., Ornato J.P., Avins A.L., and National Registry of Myocardial Infarction 2 Investigators. Bundle-branch block and in-hospital mortality in acute myocardial infarction. Ann Intern Med 129 (1998) 690-697
22. Rodriguez L.M., Timmermans C., Nabar A., Beatty G., and Wellens H.J. Variable patterns of septal activation in patients with left bundle branch block and heart failure. J Cardiovasc Electrophysiol 14 (2003) 135-141
23. Upshaw Jr. C.B. Seeing through the maze of complete left bundle branch block. J Med Assoc Ga 82 (1993) 593-599
24. Ozdemir K., Altunkeser B.B., Danis G., Ozdemir A., Uluca Y., Tokac M., Telli H.H., and Gok H. Effect of the isolated left bundle branch block on systolic and diastolic functions of left ventricle. J Am Soc Echocardiogr 14 (2001) 1075-1079
25. Sgarbossa E.B., Pinski S.L., Topol E.J., Califf R.M., Barbagelata A., Goodman S.G., Gates K.B., Granger C.B., Miller D.P., Underwood D.A., Wagner G.S., and GUSTO-I Investigators. Acute myocardial infarction and complete bundle branch block at hospital admission: clinical characteristics and outcome in the thrombolytic era. Global Utilization of Streptokinase and t-PA [tissue-type plasminogen activator] for Occluded Coronary Arteries. J Am Coll Cardiol 31 (1998) 105-110
26. Moreno R., Garcia E., Lopez de Sa E., Abeytua M., Soriano J., Ortega A., Rubio R., and Lopez-Sendon J.L. Implications of left bundle branch block in acute myocardial infarction treated with primary angioplasty. Am J Cardiol 15 (2002) 401-403
27. Baldasseroni S., Gentile A., Gorini M., Marchionni N., Marini M., Masotti G., Porcu M., and Maggioni A.P. Intraventricular conduction defects in patients with congestive heart failure: left but not right bundle branch block is an independent predictor of prognosis. A report from the Italian Network on Congestive Heart Failure (IN-CHF database). Ital Heart J 4 (2003) 607-613